TMEM129

TMEM129 is an ER-resident E3 ubiquitin ligase that drives ER-associated degradation (ERAD) of membrane substrates by coupling target ubiquitination to retrotranslocation and proteasomal turnover (PMID:24807418, PMID:25030448). It is a non-glycosylated, tri-spanning ER-membrane protein that adopts an Nexo-Ccyto orientation, placing its unconventional cysteine-only RING (RING-C2 / C4C4-type) domain in the cytosol where it catalyzes ubiquitin transfer (PMID:25030448, PMID:27854284). TMEM129 functions within a dislocation complex containing Derlin-1, Derlin-2, VIMP, and the AAA-ATPase p97, and pairs with the E2 conjugating enzyme UBE2J2 to ubiquitinate substrates at the ER membrane (PMID:24807418, PMID:25030448). It is the cellular ligase hijacked by the HCMV immunoevasin US11: US11 recruits TMEM129 via Derlin-1 to ubiquitinate and dislocate MHC class I for degradation, an activity that is genetically separable from the SEL1L/HRD1 pathway that degrades free US11 itself (PMID:25030448). The same US11–TMEM129–Derlin-1–UBE2J2 machinery targets the neonatal Fc receptor FcRn, blocking its ER export and thereby inhibiting IgG transcytosis (PMID:31289263).

1. 2014 High

   Identifying which cellular factor executes US11-driven MHC-I destruction resolved how HCMV exploits host ERAD, establishing TMEM129 as an E3 ligase embedded in a Derlin/p97 dislocation complex.

   Evidence Genome-wide shRNA screen with reciprocal Co-IP and HLA class I degradation assays

   PMID:24807418

   Open questions at the time

   • Did not demonstrate intrinsic catalytic activity in vitro
   • Endogenous (non-viral) substrates not defined
2. 2014 High

   An independent forward genetic screen confirmed TMEM129 as the ligase and showed its cysteine-only RING has intrinsic E3 activity paired with UBE2J2, defining the catalytic core of the dislocation reaction.

   Evidence Forward genetic screen in haploid KBM7 cells, in vitro E3 ligase assay, Co-IP, MHC-I degradation assay

   PMID:25030448

   Open questions at the time

   • E2/E3 ubiquitin chain topology on substrate not resolved
   • Recruitment mediated through Derlin-1 but interface not structurally mapped
3. 2014 High

   Genetic epistasis distinguished two US11-engaged routes, showing TMEM129/Derlin-1 degrades MHC-I while SEL1L/HRD1 degrades free US11, clarifying that substrate identity dictates pathway choice.

   Evidence Epistasis using KO/KD of pathway components with two orthogonal degradation substrates

   PMID:25030448

   Open questions at the time

   • Molecular basis for substrate-specific channeling between the two pathways unknown
4. 2015 Medium

   Synthesis of the screen and biochemical data consolidated TMEM129 as a RING-C2 ligase acting in an auto-regulatory loop, framing its specificity for MHC-I.

   Evidence Review synthesizing prior genetic and biochemical evidence

   PMID:26210183

   Open questions at the time

   • No new primary data
   • Specificity determinants for MHC-I not experimentally dissected
5. 2016 Medium

   Determining the membrane topology established that TMEM129 is a tri-spanning, non-glycosylated protein with a cytosolic C-terminal RING, explaining how its catalytic domain accesses cytosolic ubiquitination machinery.

   Evidence Glycosylation scanning mutagenesis and orthogonal topology mapping with fractionation

   PMID:27854284

   Open questions at the time

   • Single lab
   • Structural model of the transmembrane region absent
   • How topology coordinates with Derlin channel not shown
6. 2019 Medium

   Showing that US11 redirects TMEM129 onto FcRn extended its substrate range beyond MHC-I and linked its activity to suppression of IgG transcytosis, broadening its role in viral immune evasion.

   Evidence Co-IP, ER retention/degradation assays, and IgG transcytosis functional assay

   PMID:31289263

   Open questions at the time

   • Single lab
   • Whether FcRn is also a TMEM129 substrate in the absence of US11 unknown

• The physiological, virus-independent substrates and cellular function of TMEM129 outside the US11 hijacking context remain undefined.
• No endogenous substrate identified in the absence of US11
• Native regulation and tissue context uncharacterized
• No structural data on the RING or transmembrane domain